Brief: Shanghai Junshi Biosciences's 2023 Net Loss 2.3 Bln Yuan
28/03/2024 11:53
March 28 (Reuters) - Shanghai Junshi Biosciences Co Ltd
688180.SS :
* SAYS 2023 NET LOSS AT 2.3 BILLION YUAN ($318.18 million)
Source text
Further company coverage: 688180.SS
($1 = 7.2285 Chinese yuan renminbi)
(Reporting by Beijing newsroom)
((Ella.Cao@thomsonreuters.com;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab